News Conference News ESC 2025 PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy Michael O'Riordan September 01, 2025
News Conference News ESC 2023 Cardiac Arrest Centers Don’t Benefit OHCA Patients Without STEMI: ARREST Michael O'Riordan August 27, 2023
News ESC 2023 Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST Michael O'Riordan August 27, 2023
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News ESC 2021 GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water Shelley Wood August 27, 2021
News Conference News ESC 2020 VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban L.A. McKeown September 03, 2020
News Conference News ESC 2020 More Than Half of Patients See a GP in the 2 Weeks Before OHCA Yael L. Maxwell August 28, 2020
News Conference News ESC 2019 MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds Shelley Wood September 02, 2019
News Conference News ESC 2016 ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH Michael O'Riordan August 28, 2016
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013